Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
Kyung-Ah KimWankyo ChungHwa Young ChoiMoran KiEun Sun JangSook-Hyang JeongPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
A one-time HCV screening and DAA treatment of a Korean population aged 40-65 years would be highly cost-effective, and significantly reduce the HCV-related morbidity and mortality compared with no screening.